Cardiometabolic multimorbidity (CMM) represents a growing public health concern, particularly in postmenopausal women due to associated metabolic and inflammatory changes. This study investigated the relationship between the C-reactive protein-triglyceride-glucose index (CTI) and the development of CMM in a cohort of 2972 postmenopausal women aged 45 years or older, followed for an average of 103.53 months. A total of 395 participants developed new-onset CMM during the study period.
Key Statistical Findings
Multivariate Cox regression revealed a significant positive association between CTI and the risk of CMM, with each 1-unit increase in CTI associated with a 95% increase in risk (HR=1.95). The highest quartile of CTI demonstrated a substantially elevated risk of CMM compared to the lowest quartile (HR=3.91).
Clinical Discrimination and Subgroup Analysis
The Kaplan-Meier curve indicated a higher cumulative incidence of CMM in individuals with higher CTI levels. Subgroup analysis highlighted a stronger association between CTI and CMM in women under 60 years of age. CTI demonstrated moderate discrimination in predicting CMM, adding incremental value to existing risk models, as evidenced by the NRI and IDI. A nomogram incorporating CTI and other variables showed acceptable discrimination. **CTI** was a key factor in predicting the development of **CMM** in this cohort of **postmenopausal women**, and the results were further supported by the **NRI** and **IDI**.